312 related articles for article (PubMed ID: 17645535)
1. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy.
Vendrame M; Khurana DS; Cruz M; Melvin J; Valencia I; Legido A; Kothare SV
Epilepsia; 2007 Nov; 48(11):2116-20. PubMed ID: 17645535
[TBL] [Abstract][Full Text] [Related]
2. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A
Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683
[TBL] [Abstract][Full Text] [Related]
3. Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics.
Rainesalo S; Peltola J; Auvinen A; Keränen T
Seizure; 2005 Jan; 14(1):72-4. PubMed ID: 15642505
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation.
Tzitiridou M; Panou T; Ramantani G; Kambas A; Spyroglou K; Panteliadis C
Epilepsy Behav; 2005 Nov; 7(3):458-67. PubMed ID: 16165401
[TBL] [Abstract][Full Text] [Related]
6. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
Schmidt D; Elger CE
Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
[TBL] [Abstract][Full Text] [Related]
7. Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring.
Azar NJ; Wang L; Song Y; Abou-Khalil BW
Epilepsy Res; 2008 Mar; 79(1):78-83. PubMed ID: 18281195
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
9. Seizure exacerbation and developmental regression with carbamazepine.
Prasad AN; Stefanelli M; Nagarajan L
Can J Neurol Sci; 1998 Nov; 25(4):287-94. PubMed ID: 9827229
[TBL] [Abstract][Full Text] [Related]
10. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
11. [Oxcarbazepine in the treatment of epilepsy].
Freidel M; Krause E; Kuhn K; Peper R; Vogel H
Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
[TBL] [Abstract][Full Text] [Related]
13. Induction of epileptic negative myoclonus by oxcarbazepine in symptomatic epilepsy.
Hahn A; Fischenbeck A; Stephani U
Epileptic Disord; 2004 Dec; 6(4):271-4. PubMed ID: 15634624
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
15. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
[TBL] [Abstract][Full Text] [Related]
16. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
[TBL] [Abstract][Full Text] [Related]
17. Open prospective study on oxcarbazepine in epilepsy in children: a preliminary report.
Franzoni E; Garone C; Sarajlija J; Gualandi S; Malaspina E; Cecconi I; Moscano FC; Marchiani V
Seizure; 2006 Jul; 15(5):292-8. PubMed ID: 16554175
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic epilepsies imitating idiopathic generalized epilepsies.
Oguni H
Epilepsia; 2005; 46 Suppl 9():84-90. PubMed ID: 16302880
[TBL] [Abstract][Full Text] [Related]
19. Weight gain in children on oxcarbazepine monotherapy.
Garoufi A; Vartzelis G; Tsentidis C; Attilakos A; Koemtzidou E; Kossiva L; Katsarou E; Soldatou A
Epilepsy Res; 2016 May; 122():110-3. PubMed ID: 27010568
[TBL] [Abstract][Full Text] [Related]
20. A clinical and EEG study on idiopathic partial epilepsies with evolution into ESES spectrum disorders.
Saltik S; Uluduz D; Cokar O; Demirbilek V; Dervent A
Epilepsia; 2005 Apr; 46(4):524-33. PubMed ID: 15816946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
